INmune Bio Sets $4.5 Million Registered Direct Offering and Warrant Placement

INmune Bio Inc. agreed to sell 3 million common shares and place warrants for up to 3 million additional shares, a transaction expected to generate approximately $4.5 million in gross proceeds.

The share sale is a registered direct offering to an institutional investor. A concurrent private placement covers unregistered warrants that can be exercised for up to 3 million more shares.

The expected proceeds are before placement-agent fees and other estimated offering expenses. The company announced the agreement Wednesday, Oct. 28.